Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$8K Sell
126
-1,929
-94% -$121K 0.39% 76
2016
Q4
$129K Buy
2,055
+666
+48% +$40.7K 0.61% 43
2016
Q3
$88K Buy
1,389
+1,029
+286% +$66.6K 0.43% 87
2016
Q2
$22K Sell
360
-1,467
-80% -$89.4K 0.11% 182
2016
Q1
$104K Sell
1,827
-630
-26% -$35.1K 0.45% 74
2015
Q4
$146K Buy
2,457
+1,356
+123% +$78.1K 0.63% 42
2015
Q3
$60K Buy
1,101
+577
+110% +$37.6K 0.27% 134
2015
Q2
$35K Buy
524
+249
+91% +$16.3K 0.15% 159
2015
Q1
$16K Sell
275
-316
-53% -$19.1K 0.06% 176
2014
Q4
$39K Buy
591
+283
+92% +$17.8K 0.15% 151
2014
Q3
$18K Sell
308
-3,222
-91% -$179K 0.07% 174
2014
Q2
$199K Buy
3,530
+468
+15% +$24.6K 0.84% 28
2014
Q1
$157K Buy
3,062
+980
+47% +$49.5K 0.69% 39
2013
Q4
$110K Sell
2,082
-29
-1% -$1.43K 0.5% 72
2013
Q3
$94K Sell
2,111
-232
-10% -$10.3K 0.47% 89
2013
Q2
$97K Buy
+2,343
New +$102K 0.45% 90

Other funds holding ABBV

New York Life Trust's ABBV Position: Q1 2017 in Review

New York Life Trust reduced its AbbVie (ABBV) stake by 94% in Q1 2017, selling an estimated $121K and leaving 126 shares worth $8K. The position accounts for 0.39% of the portfolio, ranked #76.

New York Life Trust first reported a position in ABBV in Q2 2013 and has held it in 16 quarters since. The position peaked at $199K in Q2 2014. 1,727 funds tracked by Wall St. Rank hold ABBV as of Q1 2017.

  • New York Life Trust held 126 shares of AbbVie worth $8K as of Q1 2017.
  • New York Life Trust sold 1,929 AbbVie shares in Q1 2017, an estimated $121K.
  • AbbVie made up 0.39% of New York Life Trust's portfolio in Q1 2017, its #76 holding.
  • New York Life Trust first reported a position in AbbVie in Q2 2013 and has held it in 16 quarters since.
  • New York Life Trust's AbbVie position peaked at $199K in Q2 2014.
  • 1,727 funds tracked by Wall St. Rank held AbbVie as of Q1 2017.

Based on New York Life Trust's 13F filing for Q1 2017, filed 12 May 2017.